OMNI Ultrasound

01/06/2026

Polyendocrine Metabolic Ovarian Syndrome or PMOS (formerly referred to as Polycystic O***y Syndrome or PCOS), is a complex hormonal condition that affects ovulation and can significantly impact women’s health. It affects millions of women worldwide and can result in symptoms such as irregular periods, excess hair growth, skin issues, weight changes, mood shifts and difficulty conceiving.

If you suspect you have PMOS, ultrasound can help identify the hallmark signs. Get in touch with our team today.

30/05/2026

Behind every scan is years of specialist training, clinical expertise and a commitment to getting it right. At OMNI, ultrasound isn't just a tool, it's how we find answers.

27/05/2026

While many ovarian cysts are harmless and resolve on their own, some require a closer look.
Ultrasound can tell the difference, as OMNI founder Prof. George Condous explains.

23/05/2026

16/05/2026

At OMNI, we're committed to advancing the standard of gynaecological and pregnancy ultrasound in practice and beyond. Our founder, Prof. George Condous, will be presenting at a free webinar designed for clinicians and anyone involved in ultrasound looking to deepen their expertise in endometriosis.

Register via the link in bio.

14/05/2026

If you or someone you know has been diagnosed with PCOS, you may have noticed something new: it now has a different name.

PCOS is now officially known as PMOS or Polyendocrine Metabolic Ovarian Syndrome, following the largest global engagement ever conducted for a medical name change. Over 22,000 survey responses, worldwide workshops, and the voices of 56 patient organisations helped shape this decision.

The new name better reflects what we know about the condition. PMOS affects far more than the ovaries. It's a complex hormonal and metabolic condition that impacts the whole body. And critically, not everyone with PMOS has ovarian cysts, making the old name both confusing and, for many women, inaccurate.

There's a 3-year transition period where both names will be used, with PMOS fully embedded into the 2028 International Guidelines.

At OMNI Ultrasound, we're committed to staying at the forefront of evidence-based care. If you have questions about PMOS, your diagnosis, or what this change means for you, we're here to help. Learn more via the link in bio.

13/05/2026

Ultrasound has transformed our ability to identify underlying causes of infertility non-invasively, even when nothing else feels wrong. If you're trying to conceive without success, it may be worth investigating. Prof. George Condous explains.

10/05/2026

Happy Mother’s Day to every mum, mum-to-be and mother figure in our OMNI community. It’s a privilege to be part of so many journeys along the way. Wishing you a day filled with appreciation, warmth and the recognition you deserve.

We also recognise that today can be difficult for many, including those navigating loss, infertility or complex family experiences. Our thoughts are with you today and every day. 🤍

06/05/2026

An experienced support team is vital to a successful, safe pregnancy.

At OMNI, we offer a number of pregnancy ultrasound services to ensure you feel informed and comfortable no matter what trimester you’re in, including:

Early pregnancy ultrasound
Down’s Syndrome screening (Nuchal Scan)
Fetal morphology scan
Fetal growth scan
3D/4D pregnancy ultrasound

To learn more, visit our website.

02/05/2026

Clinicians at Nepean Hospital, supervised by our founder Professor George Condous, are working to improve care after pregnancy loss complications.

The study is exploring safer, evidence-based ways to manage retained products of conception (RPOC), a condition where pregnancy tissue remains in the uterus after miscarriage or termination. By using ultrasound to guide treatment decisions, researchers hope to reduce unnecessary surgery and its potential risks, while improving care and recovery for patients.

Read more via the link in website.